We therefore examined the expression of ER, PgR, HER2, Ki67, and tumor-infiltrating lymphocytes (TILs), as well as nuclear and histological grades, in tumor specimens from patients enrolled in these two studies using the currently available measurement methods. The gene discussed is ESR1; the disease is neoplasm.